CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Virosomal influenza vaccinebiological
Likely dose
Virosomal influenza vaccine 0.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01631071
NCT01631071N/ACompleted
CompareCT.gov

Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2012/2013-Season Virosomal Subunit Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations

Crucell Holland BV·interventional·Posted Jun 28, 2012·Updated Dec 20, 2013

In Brief

A clinical study evaluating Virosomal influenza vaccine for Influenza. Completed, enrolled 110 participants across 1 site.

Detailed Summary

The study is to assess whether the virosomal influenza vaccine for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 28, 2012
Enrollment StartJul 1, 2012
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.0 years ago

Interventions

Virosomal influenza vaccinebiological

Intramuscular administration (M. deltoideus) of a single dose of 0.5 mL virosomal influenza vaccine